Skip to main content
Mani Subramanian, MD, Oncology, Killeen, TX

ManiSubramanianMD

Oncology Killeen, TX

Physician

Dr. Subramanian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Subramanian's full profile

Already have an account?

  • Office

    2207 S Clear Creek Rd
    Ste 302
    Killeen, TX 76549
    Phone+1 254-526-5353
    Fax+1 254-554-5298

Education & Training

  • University at Buffalo
    University at BuffaloFellowship, Hematology and Medical Oncology, 1976 - 1978
  • Icahn School of Medicine at Mount Sinai/NYC Health and Hospitals (Elmhurst)
    Icahn School of Medicine at Mount Sinai/NYC Health and Hospitals (Elmhurst)Residency, Internal Medicine, 1975 - 1976
  • Icahn School of Medicine at Mount Sinai/NYC Health and Hospitals (Elmhurst)
    Icahn School of Medicine at Mount Sinai/NYC Health and Hospitals (Elmhurst)Residency, Internal Medicine, 1973 - 1974
  • Madurai Medical College
    Madurai Medical CollegeClass of 1971

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1983 - 2024
  • MO State Medical License
    MO State Medical License 2019 - 2020
  • NY State Medical License
    NY State Medical License 1977 - 2019
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Publications & Presentations

PubMed

Press Mentions

  • Gilead and Glympse Bio Announce Strategic Collaboration for Use of Biomarker Technology in NASH Clinical Development
    Gilead and Glympse Bio Announce Strategic Collaboration for Use of Biomarker Technology in NASH Clinical DevelopmentOctober 29th, 2019